Yale Cancer Center researchers have discovered a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases acute lymphoblastic leukemia, chronic lymphocytic leukemia, and Mantle cell lymphoma.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
